Enteral Access Technologies Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$3.37M
- Investors
-
6
Enteral Access Technologies General Information
Description
Developer of medical devices designed to improve enteral access by enabling safer placement of nasogastric feeding and decompression tubes. The company offers a tube-compatible device with dual carbon dioxide and pH indicators, enabling clinicians working with infants to reduce misplacements, avoid lung insertion, and minimize unnecessary radiation exposure.
Contact Information
Website
www.enteralaccesstech.comCorporate Office
- Liverpool Science Park
- 131 Mount Pleasant
- Liverpool L3 5TF
- England, United Kingdom
Corporate Office
- Liverpool Science Park
- 131 Mount Pleasant
- Liverpool L3 5TF
- England, United Kingdom
Enteral Access Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | 11-Nov-2025 | $3.37M | Completed | Generating Revenue | ||
| 1. Grant | 16-Dec-2020 | Completed | Generating Revenue |
Enteral Access Technologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| B Shares | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 2,083,333 | $0.013261 | $0.02 | $0.02 | 1x | $0.02 | 0.42% | |
| C1 Shares | 18,925,078 | $0.013261 | $0.02 | $0.02 | 1x | $0.02 | 3.79% |
Enteral Access Technologies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Enteral Access Technologies Patents
Enteral Access Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202100703-D0 | In-line testers | Active | 20-Jan-2021 | ||
| GB-2607553-A | In-line testers | Active | 20-Jan-2021 | ||
| EP-4280966-A1 | In-line testers with colorimetric test chambers and a detachable reservoir | Pending | 20-Jan-2021 | ||
| GB-202311899-D0 | In-line testers with colorimetric test chambers and a detachable reservoir | Active | 20-Jan-2021 | ||
| GB-2607553-B | In-line testers with colorimetric test chambers and a detachable reservoir | Active | 20-Jan-2021 | A61B10/0045 |
Enteral Access Technologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Enteral Access Technologies Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| British Design Fund | Venture Capital | Minority | ||
| Freyr Investments | Venture Capital | Minority | ||
| Namier Capital Partners | Venture Capital | Minority | ||
| Puffin Point | Family Office | Minority | ||
| WilkinsonFuture | Corporate Venture Capital | Minority |
Enteral Access Technologies FAQs
-
When was Enteral Access Technologies founded?
Enteral Access Technologies was founded in 2018.
-
Where is Enteral Access Technologies headquartered?
Enteral Access Technologies is headquartered in Liverpool, United Kingdom.
-
What is the size of Enteral Access Technologies?
Enteral Access Technologies has 10 total employees.
-
What industry is Enteral Access Technologies in?
Enteral Access Technologies’s primary industry is Therapeutic Devices.
-
Is Enteral Access Technologies a private or public company?
Enteral Access Technologies is a Private company.
-
What is the current valuation of Enteral Access Technologies?
The current valuation of Enteral Access Technologies is .
-
What is Enteral Access Technologies’s current revenue?
The current revenue for Enteral Access Technologies is .
-
How much funding has Enteral Access Technologies raised over time?
Enteral Access Technologies has raised $3.37M.
-
Who are Enteral Access Technologies’s investors?
British Design Fund, Freyr Investments, Namier Capital Partners, Puffin Point, and WilkinsonFuture are 5 of 6 investors who have invested in Enteral Access Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
